Lastimado, Generose M.
HRN: 11-89-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
12/06/2022
12/12/2022
IVT
200mg
OD
Cystic Fibrosis; CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes